Initiator Pharma A/S (STO: INIT)

Initiator Pharma Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	374	485	317	356	133	188
Market Cap Growth	47.44%	52.80%	-10.94%	167.93%	-29.18%	153.41%
Enterprise Value	352	475	268	318	121	175
Last Close Price	6.65	9.24	6.06	8.14	4.51	7.47
Forward PE	5.94	16.58	7.36	-	-	-
PB Ratio	12.94	29.13	6.23	7.36	6.84	13.51
P/TBV Ratio	19.07	29.13	6.23	7.36	6.84	13.56
Debt / Equity Ratio	-	1.38	0.37	0.38	-	-
Quick Ratio	15.40	9.34	26.54	7.10	13.01	6.89
Current Ratio	15.40	9.34	27.70	9.91	13.06	7.45
Return on Equity (ROE)	-72.71%	-101.24%	-111.44%	-85.27%	-71.53%	-62.60%
Return on Assets (ROA)	-43.56%	-43.24%	-51.13%	-41.61%	-48.68%	-40.58%
Return on Capital (ROIC)	-48.81%	-46.16%	-54.99%	-46.00%	-54.13%	-44.09%
Earnings Yield	-3.35%	-7.04%	-18.15%	-8.18%	-8.83%	-6.19%
FCF Yield	-4.31%	-5.43%	-15.43%	-13.24%	-8.18%	-6.39%
Buyback Yield / Dilution	-3.02%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%
Total Shareholder Return	-3.02%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%

Source: S&P Capital IQ. Standard template. Financial Sources.